Tocilizumab for severe COVID-19: a systematic review and meta-analysis

This systemic review and meta-analysis aimed to assess the efficacy of tocilizumab for the treatment of severe coronavirus disease 2019 (COVID-19). Candidate studies up to 24 May 2020 were identified from PubMed, Cochrane Library, Embase, medRxiv and bioRxiv. Treatment outcomes included mortality, r...

Descripción completa

Detalles Bibliográficos
Autores principales: Lan, Shao-Huan, Lai, Chih-Cheng, Huang, Hui-Ting, Chang, Shen-Peng, Lu, Li-Chin, Hsueh, Po-Ren
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier B.V. and International Society of Chemotherapy. 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7377685/
https://www.ncbi.nlm.nih.gov/pubmed/32712333
http://dx.doi.org/10.1016/j.ijantimicag.2020.106103

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7377685/
https://www.ncbi.nlm.nih.gov/pubmed/32712333
http://dx.doi.org/10.1016/j.ijantimicag.2020.106103

Ejemplares similares